Is oral medroxyprogesterone acetate (Provera) an effective form of birth control?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, Provera (oral medroxyprogesterone acetate) is NOT a birth control method.

Provera is FDA-approved for treating abnormal uterine bleeding, secondary amenorrhea, and reducing endometrial hyperplasia in postmenopausal women taking estrogen—not for contraception 1. The confusion likely arises because Depo-Provera (injectable DMPA) is an effective contraceptive, but these are different formulations with different indications.

Key Distinctions

Oral Provera (Medroxyprogesterone Acetate Tablets)

  • NOT approved for contraception
  • Typical dosing: 5-10 mg daily for 5-14 days per cycle 1
  • Used for menstrual disorders and endometrial protection in hormone therapy
  • The FDA label makes no mention of contraceptive efficacy 1

Injectable Depo-Provera (DMPA)

  • IS an effective contraceptive
  • Dosing: 150 mg IM or 104 mg subcutaneous every 12-13 weeks 2, 3
  • Typical use failure rate: 3-6% per year 4, 5, 6, 7
  • Perfect use failure rate: 0.2-0.3% per year 5, 7

Why This Matters Clinically

If a patient needs contraception, do not prescribe oral Provera tablets. The oral formulation lacks the sustained progestin levels necessary for ovulation suppression. Injectable DMPA achieves contraceptive efficacy through:

  • Consistent suppression of gonadotropins
  • Prevention of ovulation
  • Cervical mucus thickening
  • Endometrial changes that prevent implantation 2, 3

Appropriate Contraceptive Options

For patients requiring progestin-only contraception, evidence-based alternatives include 4, 6:

Highly Effective (LARC - <1% failure rate):

  • Levonorgestrel IUD (Mirena)
  • Progestin implant (Nexplanon)
  • Injectable DMPA (Depo-Provera) - 3% typical use failure

Moderately Effective (5-8% failure rate):

  • Progestin-only pills (must be taken same time daily)

Special Considerations

For patients with contraindications to estrogen (history of VTE, stroke, certain thrombophilias, positive antiphospholipid antibodies), injectable DMPA is classified as safe (Category 2) in most cases 4, 5, 6. However, DMPA should be avoided or used cautiously in:

  • Patients with positive antiphospholipid antibodies
  • Those at high risk for osteoporosis 4, 6

Counsel all DMPA users about:

  • Expected menstrual irregularities (nearly universal initially) 2, 3
  • Potential weight gain 2, 3
  • Delayed return to fertility (typically 9-18 months) 2
  • Bone density effects (largely reversible after discontinuation) 3, 8
  • Need for calcium (1300 mg/day) and vitamin D (600 IU/day) supplementation 2

Common Pitfall to Avoid

Do not assume all medroxyprogesterone acetate formulations are interchangeable. The route of administration and dosing schedule fundamentally determine whether the medication functions as contraception. Oral Provera tablets given cyclically will not prevent pregnancy and should never be relied upon for birth control.

Related Questions

Should medroxyprogesterone acetate (Provera) be discontinued in a patient presenting with vaginal bleeding?
What pre‑injection history should be obtained before administering an Antara (medroxyprogesterone acetate) injection?
What is the dosing schedule for Depo‑Provera (medroxyprogesterone acetate) for birth control?
What checklist should be used before initiating Depo‑Provera (medroxyprogesterone acetate) contraception, including pregnancy testing, contraindications, baseline assessments, counseling points, and follow‑up requirements?
For a 50-year-old woman receiving her scheduled Depo‑Provera injection who has been off sertraline 50 mg and buspirone 15 mg for about five weeks, can both medications be restarted simultaneously, and what initial dosing should be used?
What are the post‑procedure care instructions for a patient after an O‑shot (autologous platelet‑rich plasma injection into the vaginal area)?
A patient taking aripiprazole 7.5 mg orally daily is gaining weight; what weight‑neutral antipsychotic alternatives are available?
How should a patient with a serum ammonia level of 366 µmol/L be managed?
In an adult patient with refractory anxiety who is currently taking hydroxyzine 25 mg as needed and escitalopram 20 mg daily (maximum dose), what are the recommended next treatment steps?
Can consumption of energy drinks or carbonated beverages cause muscle cramps?
Is oral potassium replacement appropriate for a 59-year-old patient with serum potassium of 2.9 mEq/L?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.